{"id":"W4283325455","doi":"10.1097/01.hs9.0000843736.56298.a7","title":"S211: CLINICAL AND PATIENT-REPORTED OUTCOMES IN A PHASE 3 STUDY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) VS STANDARD-OF-CARE IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (ZUMA-7)","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Chemoimmunotherapy; Hazard ratio; Internal medicine; Oncology; Refractory (planetary science); Phases of clinical research; Surgery; Clinical trial; Lymphoma; Confidence interval; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006756591,0.0003052484,0.001280365,0.000250436,0.0000824502,0.00001034955,0.000180453,0.0001316385,0.00162035],"category_scores_gemma":[0.0002045811,0.0002602541,0.0001419668,0.0006503707,0.000137275,0.00009024134,0.0002734294,0.0005820518,0.000001672864],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002918817,"about_ca_system_score_gemma":0.0005013709,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002573675,"about_ca_topic_score_gemma":0.0007365393,"domain_scores_codex":[0.9955698,0.0004901409,0.001410681,0.0006510558,0.001404381,0.0004739586],"domain_scores_gemma":[0.9979286,0.0003005754,0.0004715094,0.0007868569,0.0003049988,0.000207515],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02628553,0.03446482,0.879133,0.0002541829,0.0001811862,0.0005636227,0.006661736,0.000006365447,0.000348134,0.000002585258,0.0001150157,0.05198379],"study_design_scores_gemma":[0.2828547,0.1255473,0.5311832,0.0003152375,0.0002061124,0.00001713175,0.0495575,0.0000542705,0.001363465,0.00001224913,0.008335871,0.0005529464],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954047,0.0009576049,0.000002565391,0.00004033896,0.0001152577,0.002372719,0.0001480674,0.00002772236,0.0009310806],"genre_scores_gemma":[0.9989232,0.00005449442,0.0001191208,0.00007534932,0.00001268891,0.0001522096,0.00006162871,0.0000714054,0.0005299488],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3479499,"threshold_uncertainty_score":0.999985,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02406320880621695,"score_gpt":0.3345384065848873,"score_spread":0.3104751977786704,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}